Company attributes
Other attributes
CB Therapeutics is a biotechnology company that focuses on the biosynthetic production of cannabinoids from sugar.
CB Therapeutics produces high-value molecules, compounds and rare ingredients from feedstock that utilizes many different kinds of hosts and systems, which includes yeast, bacteria and cell-free expression systems.
CB Therapeutics has expertise in synthetic genomics, bio-engineering and cellular production processes that is capable of producing a wide range of phytochemicals faster, more sustainably, at greater yields, with higher purity, consistency, and efficiency than competitive platforms.
CB Therapeutics focuses on the discovery, research, development and production of tryptamines, cannabinoids and other compounds and molecules for advancing Neuroscience and bringing therapeutics to the market to solve human’s most challenging mental healthcare and social problems.
The company is bringing cannabinoid and tryptamine therapeutics to the clinic and market for the treatment of depression, opioid addiction, PTSD, alcoholism, anxiety, pain, and mental healthcare and social challenges.
